Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03959995
Other study ID # ER_ACTLIFE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date June 5, 2020

Study information

Verified date June 2020
Source University of Erlangen-Nürnberg Medical School
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Menopause usually have a serious impact on a woman's life, associated with negative consequences for health and quality of life. Early preventive assessments are very difficult to implement due to the complex hormone-deficiency-induced effects on a large variety of organs and systems with estrogen receptors. In fact, only a few types of interventions have the potential to comprehensively improve the various risk factors and complaints of the menopausal transition. In detail, however, not every form of exercise training or every training protocol is effective for exerting positive effects on selected risk factors. In particular, the training concept for addressing musculoskeletal or cardio-metabolic risk factors differ fundamentally.

In several studies, we confirmed the effect of different complex training programs on risk factors of different postmenopausal female cohorts with special consideration of osteoporotic aspects. The training programs applied in this context were characterized by the consistent implementation of recognized training principles and an in general exercise intensity-oriented approach. Recent studies confirmed the effectiveness of this proceeding for women with relevant postmenopausal risk factors including low bone strength. However, the crucial issue of the most effective, feasible and easily customizable training protocol for addressing postmenopausal risk factors remains to be answered, taking into account that the majority of exercise programs were realized in an ambulatory group setting.

The aim of the study will be to evaluate the effects of an optimized physical training on risk factors and complaints of (early) postmenopausal women with special consideration of the osseous fracture risk.

Note (05.06.2020): Of importance, the intervention has to be cancelled due to COVID-19 lockdown in March 2020 after 13 months of intervention.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date June 5, 2020
Est. primary completion date March 13, 2020
Accepts healthy volunteers No
Gender Female
Age group 48 Years to 58 Years
Eligibility Inclusion Criteria:

- (early)postmenopausal women, ( normal menopause, 1-5 years post)

- Osteopenia and osteoporosis at the lumbar spine or femoral neck Bone Mineral Density (BMD) <-1.0 standard deviation (SD) T-Score, WHO)

Exclusion Criteria:

- BMD <-4.0 SD T-Score (BMD threshold for pharmaceutical therapy according to Dachverband Osteologie (DVO) guideline (mandatory for Germany, Austria, Suisse) for woman 50-60 years).

- Prevalent clinical, low-trauma fractures

- Diseases and drugs with relevant effects on bone and muscle metabolism (e.g. glucocorticoids >7.5 mg/d or bisphosphonate therapy); individual case assessment

- Diseases and drugs with relevant effects on cardiometabolic risk factors (e.g. severe hypertension with corresponding medical therapy); individual case assessment

- Severe cardiovascular events (e.g. stroke, coronary infarction) in the past.

- Other conditions, diseases that exclude exercise training in a group (=10 persons).

Study Design


Intervention

Other:
High Intensity Resistance (HIT-RT) and Endurance exercise (HIIT)
Ambulatory, consistently supervised group exercise training (3 training sessions of 40-45 min/week each). 10-12-week blocks of non-linearly periodized high intensity resistance and high impact aerobic dance exercises (HIT-setting) intermitted by 4-6-week periods of endurance-type exercise with high volume and lower intensity. Indi-vidualized training schedules for the RT-section.
Wellness
control group: 3x 10 week blocks, 1 training session/week à 45 min; stretching, light functional gymnastics, yoga with less strengthening techniques over 13 months.

Locations

Country Name City State
Germany Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg Erlangen Bavaria

Sponsors (1)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Medical School

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary BMD Lumbar Spine Bone Mineral Density (BMD) at the lumbar spine region of interest as determined by Dual Energy x-Ray Absorptiometry (DXA) from baseline to 13 month follow-up
Secondary BMD total Hip Bone Mineral Density at the total hip region of interest as determined by DXA from baseline to 13 month follow-up
Secondary Para-vertebral muscle density Muscle density at the para-vertebral region as determined by Magnetic Resonance Imaging (MRI) from baseline to 13 month follow-up
Secondary Mid-thigh muscle density Muscle density at the mid-thigh region as determined by MRI from baseline to 13 month follow-up
Secondary Metabolic Syndrome Metabolic Syndrome Z-Score according to the Internationale Diabetes Federation (IDF) from baseline to 13 month follow-up
Secondary Visceral body fat Visceral body fat as determined by Magnetic Resonance Imaging (MRI) from baseline to 13 month follow-up
Secondary Total body fat Total body fat as determined by whole body DXA from baseline to 13 month follow-up
Secondary Total Lean Body Mass Total Lean Body Mass as determined by whole body DXA from baseline to 13 month follow-up
Secondary Menopausal complaints Menopausal complaints as determined by the Menopause Rating Scale (German version. Questionnaire with 11 items; scale from 0 (no complaints/problems) to 4 (very severe complaints/problem) from baseline to 13 month follow-up
Secondary Maximum leg strength Maximum isokinetic leg extensor strength as determined by an isokinetic leg press from baseline to 13 month follow-up
Secondary Total fat rate Total fat rate as determined by Bio Impedance technique (BIA) from baseline to 13 month follow-up
Secondary Fat free mass Fat free mass as determined by BIA from baseline to 13 month follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06018467 - Senolytics to Improve Osteoporosis Therapy Phase 2
Completed NCT04122638 - Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults
Completed NCT03709381 - Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study Early Phase 1
Completed NCT03819478 - Utilizing Protein During Weight Loss to Impact Physical Function and Bone N/A
Recruiting NCT01857154 - A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate N/A
Not yet recruiting NCT04719572 - Intervention Study of Drugs in Patients Osteopenia and Osteoporosis N/A
Active, not recruiting NCT04708886 - Romosozumab in Women With Chronic SCI Phase 2